is...optimistic for the future of CNS conditions thanks to Anavex Life Sciences.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you Gregory Glenn!
“Novavax Aims to Deploy Covid-19 Vaccine by December: R&D Head”
https://www.bloomberg.com/news/videos/2020-08-05/novavax-aims-to-deploy-covid-19-vaccine-by-december-r-d-head-video
Brilacidin isn’t just for coronavirus.
With the profile it is showing, it has myriad applications.
Polymedix, Cellceutix/IPIX, the RBLs...have only scratched the surface on this next generation of therapeutics.
THE BEAST!
https://www.nytimes.com/2020/08/04/health/covid-19-vaccine-novavax.html
NOVAVAX IS THE BEST!
Hadn’t seen this website before, but it seems to have tidy summaries.
https://www.evaluate.com/vantage/articles/news/trial-results/rett-failure-sets-thin-pipeline
Wonder if there could be maternal transfer/ in utero testing?
Key thing would be administration as early as possible to affect glutamine/glutamate levels yeah?
Another thing that has been comforting...
https://cos.gmu.edu/ncbid/people/aarthi-narayanan/#.XyRL1C01ihA
Dr. Narayanan is a very capable researcher and her own curiosity in testing Brilacidin with the coronavirus might also cause her to want to test it against her previous foci (bunyaviruses, alphaviruses, and human retroviruses).
That level of professional interest coupled with peer review and multi-site testing is going to bring Brilacidin out of the shadows and into the spotlight.
4 properties apparent...
Anti fungal
Anti inflammatory
Anti bacterial
Anti viral
Defensin Mimetic (Brilacidin) is on its way to being The Big Dog.
Registration for ISV webinar...
https://isv-online.site-ym.com/events/register.aspx?id=1395521&itemid=938960fb-0c58-422a-acfe-1b4d161aa66b
We don’t need no stinking remdesivir
Brilacidin AT LOWEST CONCENTRATION is putting the smackdown on COVID-19.
Think about that then consider how many other diseases it will potentially be used for as a treatment!
$$$
Same question for NanoFlu, Rabies, and Malaria vaccine info!
Stat sig...
https://www.graphpad.com/guides/prism/7/statistics/extremely_significant_results.htm
Brilacidin for the win.
Thanks for the summary KarinCA!
Just a matter of time...
The Bargain
Trying to figure out if I could get to 500,000 shares before they release the RBL summaries. Might have to finagle a bit here and there, but if the timing works out, then it’s like having a full vault instead of just a bank account.
The “Common Cold”...
I was always under the impression that it was various rhinoviruses, but someone else brought up the fact that the common cold is caused by various strains of other coronaviruses as well.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171723/
Given Brilacidin’s punch, could it become the first response versus all the over-the-counter concoctions? These are exciting times in the battle against bacteria and viruses. It’s also a time when the pharmaceutical giants may be pulling out the stops to prevent previously unknown compounds from entering the arena.
Brilacidin will outperform BP’s old mares.
“Gilead Begins a Trial of an Inhaled Version of Its Covid-19 Drug for Less-Sick Patients”
Just wait until those RBL findings are published!
Thanks buddy.
Order on the way. Will see how it works with the morning run/bike routine.
Can this be said of any other candidates?
“Brilacidin exhibited a statistically significant (p<0.0001) and potent inhibitory effect on SARS-CoV-2, the novel coronavirus responsible for COVID-19, in a human lung epithelial cell line—reducing viral load by 95 percent and by 97 percent, compared to control, at two therapeutic concentrations tested. Based on a CC50 value—the concentration of drug at which 50 percent of cells maintain viability—Brilacidin was also shown to be non-cytotoxic in the lung cell line.”
So far I haven’t seen or heard of any other compounds with this level of efficacy or safety.
Anyone? Anything?
Is the fine print that the smaller company must hand over all rights?
IPIX could succeed as a company on Brilacidin’s properties alone.
To give it away would be the forfeiture of leadership in host defense protein mimetics.
A smooth, steady climb...
Wondering what level of consumption Japan will be at in the months ahead?
I haven’t even tasted the product yet, but will order some to taste and share.
https://getneuenergy.com/buy/6-pack-neuenergy-tabs/
Get neuenergy® for 15% off using the code:
“NEUENERGY15”
Use the code at checkout to get 15% off
your first order of neuenergy®
(Considering I have stock in the company, I might as well be familiar with the product. ??)
Latest PR...
“In Vitro Testing of Innovation Pharmaceuticals’ Brilacidin for COVID-19 Shows Consistent Anti-SARS-CoV-2 Efficacy; Manufacturing Preparation Underway for COVID-19 Clinical Trial
The Company also reports that all preferred shares and warrants outstanding have been exercised, establishing a cash balance of approximately $6 Million as of June 30, 2020“
NVAX for the vaccines.
IPIX for the therapeutic treatments.
Cold Spring Harbor Lab! Nice...
Good news out of Oyster Bay.
Stink bid is in for a few thousand more shares at .30
??
No worries.
Thanks for all that you do!
Sticky please? Or can it be added to an updated Due Diligence posting to be placed atop the message board?
Alight. They’re absolute thieves.
Company I used to work for chose poorly for our plan. Dig it: $12.95 per transaction!
Damn the 401k...
Could add 80000 shares if it weren’t for OTC/Pink restrictions.
Ah well.
GLTA. Polymedix/CTIX/IPIX will come to fruition!
Thinking...
Sell a few shares of Novavax to get even more shares of IPIX (the upside is good on both.) ??
Yeah...HIV has been notorious due to its mutation rate
Can’t even imagine how amazing Brilacidin could potentially be for knocking it back. It certainly has the characteristics of a “silver bullet”.
Consider Novavax and Serum Institute’s under-the-radar collaboration for Malaria Vaccine
“Praha Vaccines is a subsidiary of the Cyrus Poonawalla Group, the parent company of Serum Institute of India focused on manufacturing immuno-biologicals.
In March, Serum Institute of India and Novavax signed a commercial license agreement to leverage Novavax’s Matrix-M vaccine adjuvant with the institute’s malaria vaccine candidate.
Novavax president and CEO Stanley Erck said: “This acquisition provides the vital assets required to produce more than one billion doses per year.“
Now, couple that with recent news of:
“Joining the company's leadership team as chief medical officer is Filip Dubovsky, an AstraZeneca veteran. Dubovsky joins Novavax directly from the British drugmaker, where he served as head of clinical engagement and policy, plus as chief medical officer for clinical affairs. Before that role, he oversaw a portfolio of more than two dozen malaria vaccines at the PATH Malaria Vaccine Initiative.”
Yes, Novavax is well situated for NanoFlu, as well as Coronavirus, and the RSV vaccine too.
Everything is lining up for Novavax’s entire pipeline to be brought into play within 2-3 years, if not sooner.
New global vaccination powerhouse.
Gotta’ say it’s heartwarming when the whole Castagna Family purchases shares!
https://ih.advfn.com/stock-market/NASDAQ/mannkind-MNKD/stock-news/82673744/statement-of-changes-in-beneficial-ownership-4
Wish Alfred Mann were still alive for the months ahead.
Brilacidin is THE compound of the future.
We get to witness the successor to old school antibiotics!
Could someone please add petemantx’s post #302295 to the sticky section?
Thanks in advance.
Still in the retail buyer’s dream range!
Once it goes past $5 and institutions start buying, then it’s in Novavax territory.
And not just for COVID-19!
Finally getting the recognition it deserves as a defensin mimetic! SOLID!
Beat me to it!
Funding is now solidified.
Can’t wait for the entire pipeline to be fully developed!
Soon to be the world’s best vaccine company.
But hey...no big deal, right?!
“The proposed research aims to evaluate Brilacidin as a potential pan-coronavirus therapeutic, for treating SARS-CoV-2, SARS-CoV-1 and MERS-CoV, including extending the current in vitro testing of Brilacidin to in vivo testing. Longer-term objectives include potentially performing additional research to develop Brilacidin as a broad-spectrum antiviral, with possible application beyond coronaviruses, e.g., treating other viruses, such as encephalitic alphaviruses and filoviruses.”